The interactions and essential effects of intrinsic insulin-like growth factor-I on Leishmania (Leishmania) major growth within macrophages
Carregando...
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Autores
Citação
PARASITE IMMUNOLOGY, v.35, n.7-8, p.239-244, 2013
Resumo
Previously, we showed in Leishmania infections that extrinsic insulin-like growth factor (IGF)-I favored Leishmania proliferation and leishmaniasis development. In this study, the interaction of intrinsically expressed IGF-I and Leishmania (Leishmania) major in macrophages was addressed, and a key finding was the observation, using confocal microscopy, of the co-localization of IGF-I and parasites within macrophages. Following stimulation with interferon-gamma (IFN-gamma), which is known to inhibit IGF-I production in macrophages, we observed a reduction in the expression of both IGF-I mRNA and protein. This reduced expression was accompanied by a reduction in the cellular parasite load that was completely recovered with the addition of extrinsic IGF-I, which suggests an essential role for IGF-I in Leishmania growth.
Palavras-chave
confocal microscopy, insulin-like growth factor-I, Leishmania (Leishmania) major, macrophage, Interferon-gamma
Referências
- Al-Salam S, 2009, ISLETS, V1, P102, DOI 10.4161/isl.1.2.9273
- ARKINS S, 1995, MOL ENDOCRINOL, V9, P350, DOI 10.1210/me.9.3.350
- ARKINS S, 1993, ENDOCRINOLOGY, V133, P2334, DOI 10.1210/en.133.5.2334
- Contreras I, 2010, PLOS PATHOG, V6
- Costa FAL, 2000, BRAZ J MED BIOL RES, V33, P1455, DOI 10.1590/S0100-879X2000001200009
- Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004
- Gomes CMC, 2001, EXP PARASITOL, V99, P190, DOI 10.1006/expr.2001.4650
- Gomes CMC, 1998, J EUKARYOT MICROBIOL, V45, P352, DOI 10.1111/j.1550-7408.1998.tb04548.x
- Gomes CMC, 1997, ACTA TROP, V64, P225, DOI 10.1016/S0001-706X(96)00633-X
- Gomes CMD, 2000, INT J EXP PATHOL, V81, P249, DOI 10.1046/j.1365-2613.2000.00157.x
- Goto H, 1998, P NATL ACAD SCI USA, V95, P13211, DOI 10.1073/pnas.95.22.13211
- GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
- GREEN SJ, 1990, J IMMUNOL, V144, P278
- Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742
- Hewitt SC, 2010, J BIOL CHEM, V285, P2676, DOI 10.1074/jbc.M109.043471
- JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3
- Kihira T, 2009, NEUROPATHOLOGY, V29, P548, DOI 10.1111/j.1440-1789.2009.01010.x
- LIEW FY, 1990, J IMMUNOL, V144, P4794
- Mougneau E, 2011, IMMUNOL REV, V240, P286, DOI 10.1111/j.1600-065X.2010.00983.x
- Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, P2002, DOI 10.1093/NAR/29.9.E45
- Roberts SC, 2004, J BIOL CHEM, V279, P23668, DOI 10.1074/jbc.M402042200
- Vendrame CMV, 2007, SCAND J IMMUNOL, V66, P287, DOI 10.1111/j.1365-3083.2007.01950.x
- Verschure PJ, 1996, HISTOCHEM J, V28, P13, DOI 10.1007/BF02331423
- Wynes MW, 2003, J IMMUNOL, V171, P3550